Freenome

company

Investors

Number of Lead Investors
Number of Investors
11
50
Freenome is funded by 50 investors. Roche and Perceptive Advisors are the most recent investors.
Investor Name Lead Investor Funding Round
Roche Yes Corporate Round
Perceptive Advisors Yes Series D
RA Capital Management Yes Series D
Loxbridge Research Yes Seed
Andreessen Horowitz - Series D
ArrowMark Partners - Series D
Artis Ventures (AV) - Series D
Bain Capital Life Sciences - Series D
BrightEdge Fund - Series D
Byers Capital - Series D
Catalio Capital Management - Series D
Cormorant Capital - Series D
DCVC - Series D
Eventide - Series D
Farallon Capital Management - Series D
Fidelity Management and Research Company - Series D
GV - Series D
HBM Healthcare Investments AG - Series D
Intermountain Ventures - Series D
Janus Henderson Investors - Series D
Kaiser Permanente - Series D
Logos Capital - Series D
Novartis - Series D
Polaris Partners - Series D
Pura Vida Investments - Series D
Ridgeback Capital - Series D
Roche Venture Fund - Series D
Rock Springs Capital - Series D
Sands Capital Ventures - Series D
Section 32 - Series D
Soleus Capital - Series D
Suvretta Capital Management - Series D
T. Rowe Price - Series D
Cormorant Asset Management - Series C
EcoR1 Capital - Series C
Kaiser Permanente Ventures - Series C
dRx Capital - Series B
Longevity Vision Fund - Series B
Verily - Series B
Anne Wojcicki - Series A
Asset Management Ventures (AMV) - Series A
CRV - Series A
Founders Fund - Series A
Innovation Endeavors - Series A
S28 Capital - Series A
Agent Capital - Series A
Allen & Company - Series A
AME Cloud Ventures - Series A
Charles River Associates - Series A
Third Kind Venture Capital - Seed